NO20072036L - Syklisk aminderivat eller salt av dette - Google Patents
Syklisk aminderivat eller salt av detteInfo
- Publication number
- NO20072036L NO20072036L NO20072036A NO20072036A NO20072036L NO 20072036 L NO20072036 L NO 20072036L NO 20072036 A NO20072036 A NO 20072036A NO 20072036 A NO20072036 A NO 20072036A NO 20072036 L NO20072036 L NO 20072036L
- Authority
- NO
- Norway
- Prior art keywords
- salt
- amine derivative
- hydro
- disease
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004274105 | 2004-09-21 | ||
PCT/JP2005/017272 WO2006033318A1 (ja) | 2004-09-21 | 2005-09-20 | 環状アミン誘導体又はその塩 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20072036L true NO20072036L (no) | 2007-05-23 |
Family
ID=36090077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072036A NO20072036L (no) | 2004-09-21 | 2007-04-20 | Syklisk aminderivat eller salt av dette |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070197594A1 (ja) |
EP (1) | EP1795524A4 (ja) |
JP (1) | JP4748320B2 (ja) |
KR (1) | KR20070064437A (ja) |
CN (1) | CN101023055B (ja) |
AU (1) | AU2005285878B2 (ja) |
BR (1) | BRPI0515525A (ja) |
CA (1) | CA2580980C (ja) |
IL (1) | IL181897A (ja) |
MX (1) | MX2007003337A (ja) |
NO (1) | NO20072036L (ja) |
RU (1) | RU2347776C2 (ja) |
TW (1) | TW200621677A (ja) |
WO (1) | WO2006033318A1 (ja) |
ZA (1) | ZA200702333B (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5109974B2 (ja) * | 2006-07-18 | 2012-12-26 | アステラス製薬株式会社 | アミノインダン誘導体又はその塩 |
ES2624791T3 (es) * | 2006-11-21 | 2017-07-17 | Omeros Corporation | Inhibidores de PDE10 y composiciones y métodos relacionados |
US7786139B2 (en) | 2006-11-21 | 2010-08-31 | Omeros Corporation | PDE10 inhibitors and related compositions and methods |
WO2009069610A1 (ja) * | 2007-11-28 | 2009-06-04 | Astellas Pharma Inc. | 縮合インダン化合物 |
US8518933B2 (en) | 2009-04-23 | 2013-08-27 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
US8546377B2 (en) | 2009-04-23 | 2013-10-01 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
RU2014147175A (ru) | 2009-05-22 | 2015-06-27 | Эббви Инк. | Модуляторы рецепторов 5-нт и способы их применения |
CN102762554A (zh) | 2010-02-16 | 2012-10-31 | 辉瑞大药厂 | 5-ht4受体的部分激动剂(r)-4-((4-((4-(四氢呋喃-3-基氧基)苯并[d]异*唑-3-基氧基)甲基)哌啶-1-基)甲基)四氢-2h-吡喃-4-醇 |
EP2571353B1 (en) | 2010-05-21 | 2017-08-09 | AbbVie Inc. | Modulators of 5-ht receptors and methods of use thereof |
AR092924A1 (es) | 2012-10-09 | 2015-05-06 | Sanofi Sa | Derivados de pirrolidinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados |
EP3639817A4 (en) * | 2017-06-16 | 2021-03-10 | Korpharm Co., Ltd. | COMPOSITIONS CONTAINING A PTEROSIN AND THEIR DERIVATIVES WHICH ARE ACTIVE INGREDIENTS IN THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF DEGENERATIVE BRAIN DISEASES |
KR102085358B1 (ko) * | 2017-06-21 | 2020-03-05 | 고려대학교 산학협력단 | 프테로신 화합물 및 이의 유도체를 유효성분으로 포함하는 퇴행성 뇌질환 예방 또는 치료용 조성물 |
TWI812692B (zh) | 2018-03-30 | 2023-08-21 | 日商東麗股份有限公司 | 環狀胺衍生物或其藥理學上可容許之鹽之用途 |
CN110357339B (zh) * | 2019-08-14 | 2021-08-31 | 盛隆资源再生(无锡)有限公司 | 一种利用高氟高氨氮废水连续生产氟化钠的方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1470055A1 (de) * | 1963-12-07 | 1969-07-17 | Merck Ag E | Verfahren zur Herstellung von Piperidinderivaten |
CH647235A5 (de) * | 1980-02-13 | 1985-01-15 | Sandoz Ag | 4-(2,2-dialkylindan-1-yliden)piperidin derivate, ihre herstellung und verwendung. |
IE55972B1 (en) * | 1982-10-07 | 1991-03-13 | Kefalas As | Phenylindene derivatives,acid addition salts thereof,and methods of preparation |
ATE94384T1 (de) * | 1989-04-14 | 1993-10-15 | Merz & Co Gmbh & Co | Verwendung von adamantan-derivaten zur praevention und behandlung der cerebralen ischaemie. |
US5703239A (en) * | 1995-06-02 | 1997-12-30 | Bristol-Myers Squibb Company | Indanylpiperidines as melatonergic agents |
CA2220649C (en) * | 1996-12-03 | 2007-02-13 | F. Hoffmann-La Roche Ag | 4-hydroxy-piperidine derivatives |
CZ293248B6 (cs) * | 1997-06-30 | 2004-03-17 | Merz Pharma Gmbh & Co. Kgaa | 1-Aminocyklohexanový derivát a farmaceutická kompozice na jeho bázi |
US6071966A (en) * | 1997-06-30 | 2000-06-06 | Merz + Co. Gmbh & Co. | 1-amino-alkylcyclohexane NMDA receptor antagonists |
HUP0202143A3 (en) * | 1999-07-28 | 2003-12-29 | Ortho Mcneil Pharm Inc | Amine and amide derivatives as ligands for the neuropeptide y y5 receptor pharmaceutical compositions containing them and their use |
DE10050236A1 (de) * | 2000-10-11 | 2002-04-25 | Merck Patent Gmbh | Verwendung bestimmter Substanzen, die an den Sigma-Rezeptor binden, zur Behandlung von Sarkomen und Karzinomen |
JP4357802B2 (ja) * | 2001-07-05 | 2009-11-04 | 武田薬品工業株式会社 | ベンゼン環縮合5員複素環式化合物、その製造法および用途 |
WO2003004485A1 (en) * | 2001-07-05 | 2003-01-16 | Takeda Chemical Industries, Ltd. | Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof |
-
2005
- 2005-09-19 TW TW094132339A patent/TW200621677A/zh not_active IP Right Cessation
- 2005-09-20 RU RU2007115093/04A patent/RU2347776C2/ru not_active IP Right Cessation
- 2005-09-20 EP EP05785275A patent/EP1795524A4/en not_active Withdrawn
- 2005-09-20 KR KR1020077009040A patent/KR20070064437A/ko active IP Right Grant
- 2005-09-20 CN CN2005800318437A patent/CN101023055B/zh not_active Expired - Fee Related
- 2005-09-20 MX MX2007003337A patent/MX2007003337A/es active IP Right Grant
- 2005-09-20 ZA ZA200702333A patent/ZA200702333B/xx unknown
- 2005-09-20 AU AU2005285878A patent/AU2005285878B2/en not_active Ceased
- 2005-09-20 JP JP2006536375A patent/JP4748320B2/ja not_active Expired - Fee Related
- 2005-09-20 US US11/663,628 patent/US20070197594A1/en not_active Abandoned
- 2005-09-20 CA CA2580980A patent/CA2580980C/en not_active Expired - Fee Related
- 2005-09-20 BR BRPI0515525-8A patent/BRPI0515525A/pt not_active IP Right Cessation
- 2005-09-20 WO PCT/JP2005/017272 patent/WO2006033318A1/ja active Application Filing
-
2007
- 2007-03-13 IL IL181897A patent/IL181897A/en not_active IP Right Cessation
- 2007-04-20 NO NO20072036A patent/NO20072036L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1795524A4 (en) | 2009-08-05 |
KR20070064437A (ko) | 2007-06-20 |
AU2005285878B2 (en) | 2011-06-30 |
ZA200702333B (en) | 2009-05-27 |
IL181897A0 (en) | 2007-07-04 |
IL181897A (en) | 2012-05-31 |
RU2347776C2 (ru) | 2009-02-27 |
JP4748320B2 (ja) | 2011-08-17 |
CN101023055B (zh) | 2010-10-06 |
TW200621677A (en) | 2006-07-01 |
RU2007115093A (ru) | 2008-11-10 |
US20070197594A1 (en) | 2007-08-23 |
CA2580980C (en) | 2011-05-03 |
TWI337988B (ja) | 2011-03-01 |
WO2006033318A1 (ja) | 2006-03-30 |
CA2580980A1 (en) | 2006-03-30 |
BRPI0515525A (pt) | 2008-08-05 |
CN101023055A (zh) | 2007-08-22 |
AU2005285878A1 (en) | 2006-03-30 |
MX2007003337A (es) | 2007-05-21 |
JPWO2006033318A1 (ja) | 2008-05-15 |
EP1795524A1 (en) | 2007-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20072036L (no) | Syklisk aminderivat eller salt av dette | |
CY1113561T1 (el) | (2s,3r)-ν-(2-((3-πυριδινυλ)μεθυλ)-1-αζαδικυκλο[2.2.2]οκτ-3-υλ)βενζοφουραν-2-καρβοξαμιδιο, νεες μορφες αλατων και μεθοδοι χρησεως αυτων | |
NO20072978L (no) | Nye betuinderivater, preparat derav og anvendelse derav | |
NO20060167L (no) | Benzamidderivat eller salt derav | |
NO20073876L (no) | Pyrazolopyrimidinderivater som mGluR2-antagonister | |
NO20064577L (no) | Tetrahydronaftyndin-derivater nyttige som histamin H3 reseptorligander | |
ECSP066365A (es) | Anilino purinas sustituidas en la posición 6 útiles como inhibidores de rtk | |
NO20085004L (no) | Radioaktivt merkede dihydrotetrabenazinderivater og deres anvendelse som avbildningsmidler | |
ATE441630T1 (de) | Substituierte cyclopenten-verbindungen | |
NO20051966L (no) | Nye pyrimidinamidderivater og anvendelse derav | |
NO20061737L (no) | Aminosubstituerte erylamino B2 adrenergiske receptoragonister | |
NO20070067L (no) | Pyrrolopyridinderivater | |
BR0109235A (pt) | Derivados do ácido carboxìlico como antagonistas ip | |
BRPI0515851A (pt) | composto de pirimidona | |
NO20071137L (no) | Nye piperidinderivater for behandling av depresjon | |
NO20082445L (no) | Neuropeptid-2 reseptor-agonister | |
DK1954251T3 (da) | Sammensætning med langvarig frigivelse, som har jernsalt som aktiv bestanddel, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
BR0316950A (pt) | Derivados de indazol como antagonistas de crf | |
HRP20050075B1 (hr) | Primjena specifiäśnog derivata cikliäśkog amina ili njegovih farmaceutski prihvatljivih soli u lijeäśenju ili prevenciji zatajenja srca | |
CL2009000980A1 (es) | Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006). | |
NO20080669L (no) | Acetylenpiperaziner som metabotrofiske glutamatreseptorantagonister | |
BRPI0415631A (pt) | derivados de tetrazol e métodos de tratamento de distúrbios metabólico-relacionados dos mesmos | |
NO20080671L (no) | Bisykliske piperaziner som metabotrofiske glutamatreseptorantagonister | |
Yu et al. | Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters | |
NO20070831L (no) | Middel for aktivering av tilfriskning fra dysfunksjon etter starten av sentralnevrologisk sykdom. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |